Skip to main content
. 2017 May 15;6(7):1569–1575. doi: 10.1002/sctm.16-0227

Figure 2.

Figure 2

Bone marrow cellularity at baseline and at 12 months in a patient with trilineage responses to bone marrow‐derived mesenchymal stromal cells.